Journals / Turkish Journal of Obstetrics and Gynecology / 2017 / Cilt: 14 - Sayı: 2

Role of osteocalcin, tumor necrosis factor-alpha and adiponectin in polycystic ovary syndrome patients with insulin resistance

Polikistik over sendromlu hastalarda insülin direncinde osteokalsin, tümör nekroz faktörü-alfa ve adiponektinin rolü

Pages
89–93
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Different osteocalcin levels in patients with PCOS may be responsible for explaining PCOS heterogeneity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Insulin resistance (IR) seems to be the main pathogenic factor in polycystic ovary syndrome (PCOS).
📊
Key Findings & Data:Materials and Methods: A total of 60 women were divided into two groups.
💡
Conclusion & Impact:Different osteocalcin levels in patients with PCOS may be responsible for explaining PCOS heterogeneity.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Insulin resistance (IR) seems to be the main pathogenic factor in polycystic ovary syndrome (PCOS). Adiponectin and tumor necrosis factoralpha (TNF-?) are important in IR. The aim of this study was to evaluate the correlations of osteocalcin, adiponectin, and TNF-? with IR in PCOS. Materials and Methods: A total of 60 women were divided into two groups. The first group constituted 44 patients with PCOS and the control group comprised 16 healthy women. Osteocalcin, adiponectin, TNF-? levels, body mass index (BMI), and IR in the fasting state were assessed and correlations of these parameters were evaluated. Results: Homeostasis model assessment (HOMA)-IR, adiponectin, osteocalcin, and androstenedione levels were significantly increased in the PCOS group. A moderate positive correlation between BMI and HOMA-IR, a moderate negative correlation between TNF-? and osteocalcin, and a mild negative correlation between adiponectin and BMI were detected in PCOS. Conclusion: Osteocalcin may have impact on adiponectin, TNF-?, and IR levels in PCOS. Different osteocalcin levels in patients with PCOS may be responsible for explaining PCOS heterogeneity.

Özet

Amaç: Polikistik over sendromunun (PKOS) temelinde yatan en önemli mekanizma insülin direncidir (IR). Bu çalışmada PKOS'li hastalarda kan osteokalsin düzeyinin; IR, adiponektin, tümör nekroz faktörü-alfa (TNF-?) ve bazı hormonal parametrelerle olan ilişkisini değerlendirmeyi amaçladık.Gereç ve Yöntemler: PKOS tanısına uyan 44 hasta ve hiçbir rahatsızlığı olamayan 16 sağlıklı kontrol grubundan olusan toplam 60 hasta ile yapıldı. Bu hastaların kan osteokalsin, adiponektin, TNF-?, vücut kitle indeksi (VKİ) ve IR düzeyleri ölçülerek bu parametreler arasındaki ilişki incelendi.Bulgular: PKOS grubunda homeostaz model değerlendirmesi (HOMA)-IR, adiponektin, osteokalsin ve androstenedion düzeyleri anlamlı olarak yüksek bulundu.VKİ ve HOMA-IR arasında pozitif ilişki bulunurken TNF-? ve osteokalsin, adiponektin ve VKİ arasında negatif ilişki saptandı.Sonuç: PKOS'li hastalarda kan osteokalsin düzeyinin adiponektin, TNF-?, ve IR üzerine etkisi bulunmaktadır. Saptanan farklı osteokalsin düzeyleri PKOS'li hastalarda heterojeniteyi açıklamakta faydalı olabilir.

🔖

Cite This Article

ERKAN, G., TAYYAR, A. T., AÇMAZ, G., MÜDERRİS, İ. İ., BAŞKOL, G., BAYRAM, F. (2017). Role of osteocalcin, tumor necrosis factor-alpha and adiponectin in polycystic ovary syndrome patients with insulin resistance. Turkish Journal of Obstetrics and Gynecology, Cilt: 14 - Sayı: 2, 89–93. https://ajindex.com/articles/376306

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25
  2. Bayram F, Unluhizarci K, Kelestimur F. Potential utility of insulin sensitizers in the treatment of patients with polycystic ovary syndrome. Treat Endocrinol 2002;1:45-53
  3. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab 2002;87:4652-6
  4. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care 2003;26:2015-20
  5. Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003;26:3226-9
  6. Gonzalez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen speciesinduced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:336-40
  7. Barnes PJ, Karin M. Nuclear factor-B: a pivotal transcription factor in chronic inflammatory diseases. N Eng J Med 1997;336:1066-71
  8. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A 1994;91:4854-8. 9. de Luis DA, Perez Castirillon JL, Aller R, Izaola O, Bachiller C. Response of osteocalcin and insulin resistance after a hypocaloric diet in obese patients. Eur Rev Med Pharmacol Sci 2015;19:2174-9
  9. Ngarmukos C, Chailurkit LO, Chanprasertyothin S, Hengprasith B, Sritara P, Ongphiphadhanakul B. A reduced serum level of total osteocalcin in men predicts the development of diabetes in a longterm follow-up cohort. Clin Endocrinol 2012;77:42-6
  10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9
  11. Chang RJ, Nakamura RM, Judd HL, Kaplan SA. Insulin resistance in nonobese patient with polycystic ovarian disease. J Clin Endocrinol Metab 1983;57:356-9
  12. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of ob